Optimal Pharmacotherapeutic Management of Chronic Lymphocytic Leukaemia: Considerations in the Elderly

ISSN： 1170-229X

Source： Drugs & Aging, Vol.28, Iss.3, 2011-03, pp. : 163-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Pharmacotherapeutic Management of Acute Lymphoblastic Leukaemia in the Elderly

By Rousselot Philippe

Drugs & Aging, Vol. 28, Iss. 9, 2011-09 ,pp. : 749-764

Adis International

Access to resources Recommend Favorite

Management of Chronic Lymphocytic Leukaemia

By Kalil N. Cheson B.D.

Drugs & Aging, Vol. 16, Iss. 1, 2000-01 ,pp. : 9-27

Adis International

Access to resources Recommend Favorite

An update on the management of chronic lymphocytic leukaemia

By Yee Karen WL O’Brien Susan M Giles Francis J

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 7, 2004-07 ,pp. : 1535-1554

Informa Healthcare

Access to resources Recommend Favorite

Achieving Optimal Outcomes in Chronic Lymphocytic Leukaemia

By Hamblin T.J.

Drugs, Vol. 61, Iss. 5, 2001-01 ,pp. : 593-611

Adis International

Access to resources Recommend Favorite

Economic assessment on the management of chronic lymphocytic leukaemia

By Goor Kim M Schaafsma M Ronald Huijgens Peter C van Agthoven Michel

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1179-1189

Informa Healthcare

Access to resources Recommend Favorite